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Background. Activation of cell surface receptors transduces extracellular signals into cellular responses such as proliferation,
differentiation and survival. However, as important as the activation of these receptors is their appropriate spatial and
temporal down-regulation for normal development and tissue homeostasis. The Cbl family of E3-ubiquitin ligases plays a
major role for the ligand-dependent inactivation of receptor tyrosine kinases (RTKs), most notably the Epidermal Growth
Factor Receptor (EGFR) through ubiquitin-mediated endocytosis and lysosomal degradation. Methodology/Principal
Findings. Here, we report the mutant phenotypes of Drosophila cbl (D-cbl) during eye development. D-cbl mutants display
overgrowth, inhibition of apoptosis, differentiation defects and increased ommatidial spacing. Using genetic interaction and
molecular markers, we show that most of these phenotypes are caused by increased activity of the Drosophila EGFR. Our
genetic data also indicate a critical role of ubiquitination for D-cbl function, consistent with biochemical models.
Conclusions/Significance. These data may provide a mechanistic model for the understanding of the oncogenic activity
of mammalian cbl genes.
Citation: Wang Y, Werz C, Xu D, Chen Z, Li Y, et al (2008) Drosophila cbl Is Essential for Control of Cell Death and Cell Differentiation during Eye
Development. PLoS ONE 3(1): e1447. doi:10.1371/journal.pone.0001447
INTRODUCTION
Normal cellular function and tissue homeostasis is dependent on
the precise regulation of several signal transduction pathways that
control cell proliferation, cell differentiation and cell survival. Each
cell integrates an array of extracellular signals into appropriate
cellular responses. Deregulation of these processes causes devel-
opmental abnormalities and human diseases including cancer.
However, we still lack a clear understanding of how these
processes are integrated in the context of a developing organism.
The development of the retina in the Drosophila compound eye
has long been a model system to study how extra-cellular signaling
generates precise cellular differentiation patterns (reviewed by
reference [1]). The compound eye is composed of ,800
ommatidia, repetitive units each containing a precise number of
different cell types. The adult fly eye develops from a monolayer
epithelium—the eye imaginal disc. In early larval stages cells in the
eye imaginal disc proliferate to provide the cellular mass for eye
development. During mid-third instar larval stage, cellular
differentiation starts at the posterior end of the eye imaginal disc,
which coincides with formation of the morphogenetic furrow (MF)
that sweeps across the disc from posterior to anterior [1,2]. As the
MF progresses towards the anterior, cells located behind the MF
start differentiating into distinct cell types in a strict sequence to
form the ommatidium. Each ommatidium has eight photoreceptor
neurons or ‘‘R’’ cells (R1–R8). R8 is the first R cell to be specified,
and serves as the founder cell for recruitment of the other R cells in
the order R2/R5RR3/R4RR1/R6RR7, followed by four non-
neuronal cone cells during late third instar larval stage, and three
classes of pigment cells during early pupal stages [3]. Finally, after
specification of these cell types has been completed, all surplus
undifferentiated cells are removed by apoptosis [3,4]. This occurs
between 26–30 hours after puparium formation [5].
The specification of cell fate in the developing Drosophila retina is
controlled by combinatorial signaling. Two receptor tyrosine
kinases (RTKs), the epidermal growth factor receptor (EGFR) and
Sevenless (Sev), contribute to retinal development [6,7]. Activation
of EGFR by the secreted ligand Spitz (sSpi), a transforming growth
factor (TGF-a) homologue, regulates the specification of all R cells
in the developing eye, except R8 [6,8,9]. Over-expression of sSpi
causes an over-recruitment of all cell types, while expression of
dominant negative EGFR (EGFR
DN), or shifting a temperature-
sensitive EGFR allele to the non-permissive temperature leads to
an impairment of differentiation [6,10,11]. Ommatidia mutant for
argos, gap1 and sprouty, three negative regulators of EGFR, contain
extra R and cone cells surrounded by more secondary and tertiary
pigment cells in the lattice [12–18]. In addition, EGFR signaling is
utilized for cell survival during Drosophila eye development, due to
its negative regulation of hid, a cell death-inducing gene [19–21].
In contrast to the EGFR which controls the development of all R
cells in the ommatidium except R8, sev is required only for R7
differentiation [22].
As important as the activation of cell surface receptors is their
inactivation for appropriate control of cell number and differen-
tiation. The proto-oncogene Casitas B-lineage lymphoma (Cbl)
was first identified as a retroviral transforming gene product that
induces pre-B cell lymphomas and myeloid leukemia [23]. Cbl is
involved in many signaling events through its function as a multi-
domain adaptor protein and has been best characterized as a
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This concept grew out of genetic studies performed in C.elegans in
which Sli-1, the Cbl ortholog, attenuates the activity of Let-23, the
EGFR equivalent, in vulval development. [26]. Mammals contain
three Cbl genes known as c-Cbl, Cbl-b and Cbl-3, which function
as negative regulators of EGFR [25,27,28]. Knock-out mice of c-
cbl, cbl-b and cbl-3 have no obvious developmental phenotypes
except in the immune system suggesting that they are functionally
redundant [29–32]. Drosophila has only one cbl gene, referred to as
D-cbl [33–35], eliminating the problem of redundancy, and the
genetic characterization of D-cbl mutants may reveal more
information about its oncogenic role. For example, an isoform of
D-cbl, which mimicked the oncogenic viral cbl (v-cbl), demonstrated
that v-cbl acts in a dominant negative manner [35]. Furthermore,
consistent with studies in C.elegans and mammalian cell culture, D-
Cbl has been shown to function as a negative regulator of EGFR
during dorsoventral patterning in oogenesis and guided migration
of border cells [36,37]. A loss-of-function analysis of D-cbl for eye
development in Drosophila has not been reported.
Mechanistically, Cbl binds tyrosine-phosphorylated EGFR
through its tyrosine kinase binding (TKB) domain [38] (see also
Fig. 1K). The E3 ligase activity of the RING domain of Cbl
directs the mono-ubiquitination of activated EGFR at multiple
sites, which promotes endocytosis and endosomal sorting for
lysosomal degradation of the receptors [39–43]. D-cbl encodes two
alternatively spliced isoforms, D-cblSHORT (D-cblS) and D-
cblLONG (D-cblL), both of which contain the TBK and the
RING E3 ubiquitin ligase domains, while D-CblL also has proline-
rich (SH3 binding) and UBA domains similar to c-Cbl and Cbl-b
[33–35] (see Fig. 1K).
Here, we present the characterization of the D-cbl mutant
phenotype for eye development. D-cbl mutants display overgrowth
Figure 1. Identification and characterization of D-cbl mutants. (A) Wild-type (WT) fly showing normal eye phenotype. (B) GMR-hid ey-FLP (GheF)
small eye phenotype. (C,D) GheF;D-cbl
K26 and GheF;D-cbl
7 mosaics significantly suppress the GMR-hid small eye phenotype. Genotype: GheF; D-cbl
FRT80/P[w
+] FRT80 (E,G) Scanning electron micrograph (SEM) of wild-type adult eye (E) and head (G). (F,H) ey-FLP/Minute-induced mosaics of D-cbl
K26
display rough eyes (F) and enlarged heads (H). Genotype: ey-FLP; D-cbl
K26 FRT80/M(3)i55 FRT80. (I,J) Eye-antennal discs of 3
rd instar larvae of D-cbl
K26
mosaics (I) are larger compared to wild-type (J). Scale bar 20um. (K) Domain structure of long (L) and short (S) isoforms of D-cbl. The relative locations
of three non-sense mutations and two missense mutations in D-Cbl are indicated. D-cbl
L31 and D-cbl
7 affect the same residue in the RING domain.
TKB-Tyrosine Kinase binding domain; L–Linker; RF-RING finger; UBA-ubiquitin-associated domain.
doi:10.1371/journal.pone.0001447.g001
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increased numbers of photoreceptors (mostly R7), cone and
pigment cells. Genetic interaction tests indicate that D-cbl regulates
the EGFR pathway during eye development consistent with its
proposed role as negative regulator of EGFR. Our genetic data
indicate a critical role of ubiquitination for D-cbl function, in
accord with biochemical models. In summary, these data provide
a genetic model for the understanding of the oncogenic activity of
mammalian cbl genes.
RESULTS
Isolation and characterization of D-cbl mutants
In a mutagenesis screen, we isolated five mutant D-cbl alleles as
recessive suppressors of the small eye phenotype caused by
expression of the pro-apoptotic gene hid under control of the eye-
specific GMR enhancer (GMR-hid; Fig. 1A–D). For details about the
GMR-hid suppressor screen see Material and Methods, and
references [44–46]. Because D-Cbl is a known negative regulator
of EGFR, and because increased EGFR activity inhibits the pro-
apoptotic function of Hid [19–21], the isolation of D-cbl mutants as
suppressors of GMR-hid can be explained by its effect on EGFR.
However, what sparked our interest in characterizing D-cbl for eye
development are the mutant phenotypes without GMR-hid expres-
sion. The eyes appear rough and bulgy with larger ommatidia
(Fig. 1E, F), and D-cbl mutant heads are overgrown (Fig. 1G, H).
The overgrowth phenotype is already visible in eye-antennal
imaginal discs of 3
rd instar larvae (Fig. 1I, J). Both, the strong
rough eye and the overgrowth phenotype cannot be solely explained
for by inhibition of apoptosis. Thus, we characterized the D-cbl
mutant phenotype during eye development in more detail.
DNA sequencing revealed missense and non-sense mutations
(Fig. 1K). D-cbl
7 and D-cbl
L31 affect the same residue, the highly
conserved Arg406 residue in the RING domain. The remaining
alleles, D-cbl
K26, D-cbl
4 and D-cbl
8 introduce premature STOP
codons at positions 60, 116 and 178, respectively (Fig. 1K). D-cbl
4
is identical to a previously isolated allele, D-cbl
F165 [36]. At least D-
cbl
K26 can be considered a null allele of D-cbl. Interestingly, all
isolated alleles affect both the large and the small isoform of D-cbl.
We did not recover mutant alleles that affect only the large
isoform. All experiments in this study were performed with at least
two alleles, the null allele D-cbl
K26 and the RING domain mutant
D-cbl
7, both of which show identical results.
D-Cbl regulates the EGFR pathway in the Drosophila
eye
D-Cbl has previously been shown to be a negative regulator of
EGFR signaling during dorsoventral patterning in oogenesis and
border cell migration [36,37]. A similar loss-of-function analysis of
D-cbl has not been done for eye development. We have performed
several genetic interaction tests to determine whether D-Cbl controls
EGFR signaling during eye development. First, heterozygosity of D-
cbl considerably rescued the rough eye phenotype caused by over-
expression of dominant negative ras
N17 (Fig. 2A, D). Second, D-
cbl
K26 dominantly suppresses the eye phenotype caused by mis-
expression of the active form of the repressor yan (yan
act)( Fig. 2B, E),
a target gene negatively regulated by EGFR signaling [47,48].
Third, to more directly assess a role of D-cbl for the regulation of
EGFR, we analyzed the effect of D-cbl mutants on the small eye
phenotype caused by expression of a dominant negative allele of
EGFR, EGFR
DN [6], under control of the eye-specific enhancer GMR
(GMR-EGFR
DN)( Fig. 2C). EGFR
DN lacks the intracellular tyrosine
kinase domain, but leaves the transmembrane and extracellular
domains intact [6]. EGFR
DN is able to dimerize with endogenous
EGFR,but trans-phosphorylation upon ligand binding does not take
place and thus the dimer is unable to signal. However, the inhibition
of endogenous EGFR by EGFR
DN is not complete as some R cells
still survive and differentiate [6] (data not shown), which is not
observed in strong EGFR mutant clones [49]. Thus, the small eye
phenotype of GMR-EGFR
DN is caused by partial inhibition of
endogenous EGFR. In D-cbl
K26 mutant clones, the GMR-EGFR
DN
Figure 2. Genetic interaction between D-cbl and the EGFR pathway. (A,D) The rough eye caused by over-expression of dominant negative ras
N17
under the sevenless promoter (sev-ras
N17)( A) is considerably suppressed when heterozygous for D-cbl
K26 (D). Genotype in (D): sev-ras
N17; D-cbl
K26/+.
(B,E) The small eye phenotype caused by sevenless-induced expression of activated yan (sev-yan
act)( B) is dominantly suppressed by heterozygosity
for D-cbl
K26 (E). Genotype in (E): sev-yan
act ; D-cbl
K26/+. (C,F) Overexpression of EGFR
DN under the control of the GMR enhancer (GMR- EGFR
DN) causes a
small eye (C). Genotype: GMR-Gal4 UAS-EGFR
DN. GMR-EGFR
DN is recessively suppressed in D-cbl
K26 mosaics (F). Genotype: ey-Flp; GMR-Gal4 UAS-
EGFR
DN; D-cbl
K26 FRT80/P[ubi-GFP] FRT80.
doi:10.1371/journal.pone.0001447.g002
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loss of D-cbl partially restores the activity of endogenous EGFR
inhibited by EGFR
DN. Combined, these data suggest that D-cbl
mutants contain increased EGFR activity suggesting that D-cbl
negatively controls EGFR activity.
To further confirm this notion we tested three molecular
markers in loss-of-function and gain-of-function analyses of D-cbl.
First, phospho-tyrosine labeling (p-Tyr) as a marker of RTK
activity is increased in D-cbl clones in third instar larval eye discs
(Fig. 3A). This is well visible in D-cbl clones crossing the MF and
posterior to the MF (Fig. 3A). In the reverse experiment,
overexpression of D-cbl, p-Tyr labeling is significantly reduced
(Fig. 3B). Because EGFR is the only known RTK acting posterior
to the MF in eye development (except Sev which we can exclude
as a target of D-cbl, see below), the increased p-Tyr labeling is
mainly caused by increased EGFR activity.
Second, in wild-type third instar larval eye discs, immunolabel-
ing with dpERK, an antibody that recognizes activated MAPK
acting downstream of EGFR, is detectable in one ommatidial
column immediately posterior to the MF [50] (Fig. 3E). Further
posteriorly, dpERK is not detectable suggestive of MAPK
inactivation. In D-cbl mutant clones, dpERK labeling persists
further posteriorly to the MF (Fig. 3C) suggesting lack of MAPK
inactivation. Furthermore, the reverse experiment, overexpression
of D-cbl, results in loss of dpERK labeling (Fig. 3D).
The third molecular marker used is Yan, a transcriptional
repressor in the nucleus. In response to EGFR signaling, yan
transcription is inhibited and Yan protein is proteolytically
degraded [47,48]. In pupal eye discs 35 hours after puparium
formation (APF) Yan protein is strongly reduced in D-cbl clones
(Fig. 3F) suggesting that they contain increased EGFR activity.
Taken together, these data suggest that D-cbl negatively regulates
EGFR signaling during eye development.
D-cbl mutants block apoptosis and cause over-
recruitment of all cell types in the eye
In the Drosophila eye, EGFR signaling is utilized for cell survival
and cell differentiation. Because D-cbl mutants cause increased
EGFR signaling, we tested whether this has consequences for cell
survival and cell differentiation in the fly eye. EGFR function is
anti-apoptotic due to its negative regulation of hid [19–21].
Developmental cell death during eye development is maximal
between 26 and 30 hours after puparium formation (APF) when
surplus, undifferentiated cells are eliminated [5]. This elimination
requires the pro-apoptotic function of hid [20,21,51]. To
determine whether D-cbl mutants affect cell death, we labeled
28 hours APF eye discs with an antibody that recognizes cleaved
and thus activated Caspase-3 (Cas3). In D-cbl
K26 mutant clones,
developmental cell death is significantly blocked (Fig. 4A, B). This
finding is consistent with the isolation of D-cbl mutants as
suppressors of GMR-hid (Fig. 1C, D).
Next, we tested whether D-cbl mutant clones display differen-
tiation defects. The eye disc is fully differentiated by 42 hrs APF
Figure 3. D-cbl regulates EGFR pathway activity. In panels (A–E), posterior is to the right. The morphogenetic furrow is marked by a white
arrowhead. D-cbl clones in (A,C,F) and D-cbl overexpressing clones in (B,D) are marked by the absence of GFP. Genotype in (A,C,F): ey-Flp; D-cbl
K26
FRT80/P[ubi-GFP] FRT80; genotype in (B,D): hs-Flp; tub.GFP.Gal4/UAS-D-cblLA18 (.=FRT); genotype in (E): wild-type. (A,A’) p-Tyr labeling is
increased in D-cbl clones. (B,B’) Overexpression of D-cbl suppresses p-Tyr labeling. (C,C’) dp-ERK labeling persists in D-cbl mutant clones beyond the
normal labeling immediately posterior to the MF (see arrows, compare to (E)). (D,D’) Overexpression of D-cbl suppresses dp-ERK labeling in third
instar larval eye discs. (E) dpERK labeling in third instar wild-type eye imaginal discs is restricted to one ommatidial column posterior to the MF. (F,F’)
Yan protein is reduced in D-cbl mutant clones in 35 hours APF eye discs.
doi:10.1371/journal.pone.0001447.g003
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marker, revealed that each D-cbl mutant ommatidium contains on
average 11.4561.03 (n=35) R cells compared to eight in wild-
type ommatidia (Fig. 4C, D). In addition, D-cbl mutant
ommatidia contain up to eight cone cells compared to four in
wild-type ommatidia (Fig. 4E, F) and about three primary
pigment cells instead of two in wild-type (Fig. 4G, H). The total
numbers of secondary and tertiary pigment cells has increased
from nine in wild-type to an average of fourteen per D-cbl
ommatidium (Fig. 4G, H). In summary, these data show that D-
cbl mutants cause increased cellular survival and over-recruitment
of all cell types disrupting the regular array of the ommatidia in the
developing Drosophila eye.
D-cbl specifically affects R7 development
We determined whether the over-recruitment of R cells in D-cbl
clones affects all photoreceptors randomly, or specific types of
photoreceptors. Labeling with antibodies directed against Rough
(R2,5,3,4-specific) and Seven-up (Svp, R3,4,1,6-specific) did not
reveal significant differences between D-cbl and wild-type tissue
(Fig. 5A–D). However, labeling with an antibody against Prospero
(Pros), a R7 marker, reveals 4.560.53 (n=35) cells per D-cbl
mutant ommatidium whereas in wild-type only one cell is detected
(Fig. 5E, F). To determine whether the additional Pros-positive
cells have photoreceptor character, we performed Pros and Elav
double labelings. In D-cbl mutant clones, all Pros-positive cells are
Elav-positive, suggesting that most, if not all, additional photore-
ceptors in D-cbl ommatidia are R7 cells (Fig. 5G, H). Thus,
among the R cells, D-cbl specifically affects the specification of R7.
A similar and specific increase in the number of R7 cells has been
observed in eye tissue mutant for other negative regulators of
EGFR signaling including argos, gap1, and sprouty [12,16–18].
Thus, the over-recruitment phenotype in D-cbl mutants is typical
for increased EGFR activity.
Loss of D-cbl can compensate for loss of sevenless
In addition to EGFR, Sevenless (Sev), a second RTK, is involved in
eye development. sev is only required for R7 specification and
consequently sev mutants do not contain R7 cells [22]. However,
expression of dominant active sev constructs gives rise to the
recruitment of multiple R7 cells [52], similar to the D-cbl phenotype.
Thus, it is formally possible that D-cbl also regulates Sev.
We tested this possibility. If the additional R7 cells in D-cbl
clones result from hyper-activity of Sev, then these cells should
require sev for their specification. However, genetic removal of sev
using the null allele sev
d2 [53] has no effect on R7 specification in
D-cbl
K26 mosaic background (Fig. 6). The average number of total
R cells in sev
d2, D-cbl
K26 mutant ommatidia is 11.1260.74 (n=35),
containing more than four R7 cells per ommatidium (Fig. 6). The
GFP-positive area is single mutant for sev
d2 and hence does not
form R7 (Fig. 6B, D). Thus, in D-cbl
K26 mutants, the R7 cells can
complete their differentiation program even in the absence of Sev,
suggesting that the increase of EGFR signaling in D-cbl
K26 can
compensate for loss of Sev. A similar sev-independent mode of R7
specification has been observed for other negative regulators of the
EGFR pathway such as gap1 and sprouty [16-18].
DISCUSSION
The phenotypic characterization of D-cbl mutants for eye
development in Drosophila allows making four important conclu-
Figure 4. Over-recruitment of all cell types in D-cbl mutant
ommatidia. Genotype in all panels: ey-Flp; D-cbl
K26 FRT80/P[ubi-GFP]
FRT80. (A,B) Cell death detected by cleaved (activated) caspase-3 (Cas3)
staining is significantly reduced in D-cbl
K26 mutant clones in 28 hours
APF eye discs. Outlines of some clones are shown in (B). (C–F) Anti-Elav
staining for photoreceptor cells (C,D) and anti-Cut staining for cone
cells (E,F) in 42 hrs APF pupal discs. 11.45 R cells and up to eight cone
cells are visible in D-cbl
K26 ommatidia. (G–H) Anti-Dlg labeling of 42 hrs
APF pupal discs visualizes the outline of cells and allows determining
the number of pigment cells in D-cbl
K26 mutant clones of pupal eye
imaginal discs.
doi:10.1371/journal.pone.0001447.g004
Figure 5. D-cbl affects R7 specification. Genotype in all panels: ey-Flp;
D-cbl
K26 FRT80/P[ubi-GFP] FRT80. (A,B) R3,4 and R1,6 are detected using
anti-Svp antibody (red). (C,D) Expression of Rough (red) in R2,5,3,4 cells
and Elav (blue) in all R cells. In D-cbl
K26 clones, R1-R6 cells are normal in
number. (E–H) Specific increase of R7 cells as indicated by double
labeling with anti-Prospero (Pros) (red) and anti-Elav (blue) antibodies.
doi:10.1371/journal.pone.0001447.g005
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regulation of EGFR activity. Second, loss of D-cbl causes severe
mis-specification and over-recruitment defects. Third, loss of D-cbl
blocks developmental apoptosis. Fourth, loss of D-cbl causes tissue
overgrowth at the organismal level, providing a model to study the
oncogenic activity of mammalian cbl genes.
D-Cbl negatively regulates EGFR
D-cbl mutant ommatidia contain increased numbers of R7, cone
and pigment cells. Similar phenotypes have been observed in
mutants of other negative regulators of the EGFR pathway such as
gap1, argos and sprouty [12,16-18]. We also confirmed a regulatory
role of D-cbl for EGFR activity in genetic interaction studies
(Fig. 2). Furthermore, using the molecular markers p-Tyr,
dpERK and Yan as readouts for EGFR activity we showed that
D-cbl clones contain increased RTK and MAPK activity. Likewise,
overexpression of D-cbl blocks p-Tyr and dpERK labeling. Thus,
the D-cbl mutant phenotypes in the eye are consistent with
increased EGFR activity and suggest that D-Cbl negatively
regulates EGFR, in accord with previous reports [34,36,37].
In contrast to argos, gap1 and sprouty, D-cbl does not appear to
regulate all RTKs. For example, D-cbl does not influence Torso
[36], a RTK involved in specification of the termini in the
Drosophila embryo [54]. Here, we have demonstrated that D-cbl
does not control the Sev RTK. This difference likely reflects the
direct mode of EGFR regulation by D-cbl, while argos, gap1 and
sprouty act downstream in the Ras/MAPK pathway which is
shared by all RTKs. Biochemical data has demonstrated that
mammalian Cbl proteins directly bind to tyrosine-phosphorylated
EGFR and ubiquitylates it for endocytosis and lysosomal
degradation [38–43]. Although we have not verified a similar
biochemical mechanism for the interaction between Drosophila
EGFR and D-Cbl, it is likely that the mechanism is similar. This
notion is supported by the isolation of two D-cbl alleles affecting the
RING domain (Fig. 1K). The RING domain contains an E3
ubiquitin ligase activity which targets the EGFR for ubiquitylation
[39]. The mutant phenotype of D-cbl
7 affecting the RING domain
is indistinguishable from the null allele D-cbl
K26 (data not shown),
further supporting an essential role of ubiquitylation for D-cbl
function.
It is unclear why only the number of R7 cells is affected whereas
the remaining R cells are normal in number although R1–R6 also
require the EGFR for specification. However, it suggests that the
sequence of events during R cell specification is normal in D-cbl
clones. The fact that D-cbl clones contain up to four additional R7
cells is likely due to the fact that R7 and the four cone cells are
developmentally equivalent. These five cells express sev and all
have the capacity to become R7 if Sev or downstream components
are activated [52]. Thus, the additional R7 cells in D-cbl clones
likely represent transformed cone cells.
However, this transformation does not mean that the cone cells
are lost in D-cbl clones. In contrast, we even observe an over-
recruitment of cone cells. Interestingly, the cone cell over-
recruitment in D-cbl mutants does not occur during pupal stages
as suggested for gap1 [16]. It occurs at the correct developmental
time in late third instar eye development (data not shown). Thus,
the over-recruitment of several different cell types in D-cbl clones
follows the same rules of reiterative use of the EGFR as compared
to wild-type.
EGFR-independent phenotypes of D-cbl
Despite the fact that the D-cbl mutant phenotypes are similar to the
ones described for argos, gap1 and sprouty, we noticed at least two
phenotypes which appear to be specific for D-cbl. First, D-cbl
mutant heads and imaginal discs are overgrown (Fig. 1). Second,
the spacing between the ommatidial clusters is increased (see
examples in Fig. 4D, 4F, and 6D). Similar phenotypes have not
been observed for gap1, argos and sprouty [12–18] (data not shown).
It is unclear how these phenotypes are caused, but they may be
independent of EGFR. Further studies are needed to clarify these
observations.
Implications for mammalian Cbl and oncogenesis
This work may also have some important implications for our
understanding of the oncogenic nature of mammalian cbl [55].
Increased proliferation and reduced apoptosis are hallmarks of
cancer [56]. v-cbl is a retroviral transforming oncogene causing
pre-B lymphoma and myeloid leukemia [23]. v-cbl contains only
the TKB domain [24] and behaves genetically as a dominant
negative mutant [35]. Furthermore, inappropriate activation of
mammalian EGFR can lead to various forms of human cancers
[57–60]. Thus, genetic studies in model organisms may contribute
to our understanding of oncogenic processes in mammals.
MATERIALS AND METHODS
Identification of D-cbl mutant alleles
Eye-specific expression of hid under GMR enhancer control (GMR-
hid) results in an eye ablation phenotype (Fig. 1B). Using the
GMR-hid ey-FLP (GheF) method [44], we conducted an EMS-
mutagenesis screen for chromosome arm 3L to identify recessive
suppressors of the GMR-hid eye ablation phenotype. This method
induces homozygous mutant clones in the eye by ey-FLP/FRT-
mediated mitotic recombination in otherwise heterozygous
background [61]. For GheF screening, ey-FLP; FRT80 males were
incubated with 25 mM EMS in 5% sucrose solution for 24 hours.
After recovery for 3 hours, they were mated to GheF; FRT80 P[w
+]
females and incubated at 25uC. 45,000 F1 progeny were
screened for suppression of the GMR-hid small eye phenotype. In
the screen for 3L, 4 dronc [44] and 5 D-cbl alleles (this study) were
recovered.
Figure 6. Loss of D-cbl compensates for loss of sevenless. The entire
disc is mutant for sev
d2. Homozygous D-cbl clones are marked by the
absence of GFP. Anti-Pros (red) labels R7 cells, and anti-Elav (blue) labels
all R cells. The R7 cells are absent in sev
d2 ommatidia, while 4.1260.74
(n=35) R7 cells are present in sev
d2;D-cbl
K26 double mutant ommatidia.
Genotype: sev
d2/Y; ey-FLP/+ ; FRT80 D-cbl
K26/FRT80 P[ubi-GFP].
doi:10.1371/journal.pone.0001447.g006
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Fly crosses were conducted using standard procedures at 25uC. Pupal
developmental ages are expressed as hours after puparium formation
(APF) with white pre-pupae defined as 0 hour APF. The following
stocks were used: D-cbl
K26 and D-cbl
7 (this study), GMR-hid
10 [62], ey-
Flp;P[ubi-GFP]FRT80B(providedbyGeorgHalder),UASp-P35 [63],
UAS-EGFR
DN [6], sev-ras
N17 [64], sev-yan
act [47], sev
d2 [53]. To
generate D-cbl mutant clones, D-cbl
K26 FRT80B and D-cbl
7 FRT80B
flies were crossed to ey-FLP; P[ubi-GFP] FRT80B. Clones are marked
by loss of GFP. GMR-EGFR
DN is GMR-Gal4 UAS-EGFR
DN.
Immunohistochemistry
Eye imaginal discs from the indicated larval or pupal stages were
dissected and immunohistochemical labeling was performed as
described [65]. The following antibodies were used: rat anti-Elav
(1:60) and rabbit anti-phosphotyrosine antibody (1:500, both
provided by G. Halder); anti-Svp (1:100, provided by R. Schulz);
anti-Rough (1:50, provided by K. Choi); Rabbit anti-cleaved
Caspase-3 (1:200; Cell Signaling Technology); dp-ERK (1:2,000;
Sigma); anti-Pros (1:50), mouse anti-Dlg (1:50) anti-Yan (1:40),
anti-Cut (1:100) (all DSHB). Fluorescently-conjugated secondary
antibodies are from Jackson ImmunoResearch and were used at
dilutions of 1:400. Images were captured using a Olympus Optical
FV500 confocal microscope.
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